Publications

 

Scientific work published in peer-reviewed journals in the years 2004-2012:

2012

 

Wahl K, Siegemund M, Lehner F, Vondran F, Nüssler A, Länger F, Krech T, Kontermann R, Manns MP, Schulze-Osthoff K, Pfizenmaier K, Bantel H.

Increased apoptosis induction in hepatocellular carcinoma by a novel tumor-targeted TRAIL fusion protein combined with bortezomib.

Hepatology. 2012 Sep 18.

 

Vondran FW, Eiermann E, Thaiss F, Schwinzer R, Nashan B, Koch M.

Response to comments made by Atif on “In vitro and in vivo proof of tolerance after two-step haploidentical bone marrow and kidney transplantation of the same donor.

Transplantation. 2012 Sep 15;94(5):e27-8.

 

Schrem H, Reichert M, Reichert B, Becker T, Lehner F, Kleine M, Bektas H, Johanning K, Strassburg CP, Klempnauer J.

Value of the SOFA score as a predictive model for short-term survival in high-risk liver transplant recipients with a pre-transplant labMELD score ≥ 30..

Langenbecks Arch Surg 2012 Jun;397(5):717-26.

 

Stankov MV, Panayotova-Dimitrova D, Leverkus M, Vondran FW, Bauerfeind R, Binz A, Behrens GM.

Autophagy inhibition due to thymidine analogues as novel mechanism leading to hepatocyte dysfunction and lipid accumulation.

AIDS. 2012 Aug 18.

 

Kemter E, Lieke T, Kessler B, Kurome M, Wuensch A, Summerfield A, Ayares D, Nagashima H, Baars W, Schwinzer R, Wolf E.

Human TNF-related apoptosis-inducing ligand-expressing dendritic cells from transgenic pigs attenuate human xenogeneic T cell responses.

Xenotransplantation 2012 Jan-Feb;19(1):40-51.

 

Reichert B, Becker T, Weismüller TJ, Kleine M, Zachau L, Johanning K, Lehner F, Klempnauer J, Schrem H.

Value of the preoperative SOFT-score, P-SOFT-score, SALT-score and labMELD-score for the prediction of short-term patient and graft survival of high-risk liver transplant recipients with a pre-transplant labMELD-score ≥30.

Ann Transplant 2012 Apr-Jun;17(2):11-7.

 

Vondran FW, Timrott K, Kollrich S, Klempnauer J, Schwinzer R, Becker T.

Decreased frequency of peripheral CD4⁺CD161⁺ Th₁₇-precursor cells in kidney transplant recipients on long-term therapy with Belatacept.

Transpl Int 2012 Apr;25(4):455-63.

 

Kleine M, Schrem H, Vondran FWR, Krech T,  Klempnauer J, Bektas H.
Extended surgery in advanced pancreatic endocrine tumours.
Br J Surg. 2012 Jan;99(1):88-94.

 

Vondran FW, Eiermann E, Thaiss F, Schwinzer R, Nashan B, Koch M.

In vitro and in vivo proof of tolerance after two-step haploidentical bone marrow and kidney transplantation of the same donor.

Transplantation. 2012 Mar 27;93(6):e23-5.

 

 

2011

 

Kleine M, Joahnning K, Kousoulas L, Schrem H, Lehner F, Bektas H, Klempnauer J, Kaaden S.

Observations with impact on the indication for kinetic therapy in critically ill liver transplant patients.

Ann Transplant 2011 Oct-Dec;16(4):25-31.

 

Lieke T, Nylén S, Eidsmo L, Schmetz C, Berg L, Akuffo H.

The interplay between Leishmania promastigotes and human Natural Killer cells in vitro leads to direct lysis of Leishmania by NK cells and modulation of NK cell activity by Leishmania promastigotes.

Parasitology. 2011 Sep 9:1-12.

 

Timrott K, Vondran FW, Jaeger MD, Gottlieb J, Klempnauer J, Becker T.

Incidence and outcome of abdominal surgical interventions following lung transplantation-a single center experience.

Langenbecks Arch Surg. 2011 Dec;396(8):1231-7.

 

Bektas H, Kleine M, Tamac A, Klempnauer J, Schrem H.

Clinical application of the hanover classification for iatrogenic bile duct lesions.

HPB Surg 2011;2011:612384.

 

Lieke T, Gröbe D, Blanchard V, Grunow D, Tauber R, Zimmermann-Kordmann M, Jacobs T, Reutter W.

Invasion of Trypanosoma cruzi into host cells is impaired by N-propionylmannosamine and other N-acylmannosamines.

Glycoconj J. 2011 Jan;28(1):31-7.

 

 

2010

 

G. Tasew, S. Nylen, T. Lieke, B. Lemu, H. Meless, N. Ruffin, D. Wolday, A. Asseffa, H. Yagita, S. Britton, H. Akuffo, F. Chiodi, L. Eidsmo.

Systemic FasL and TRAIL neutralisation reduce leishmaniasis induced skin ulceration.

PLoS Negl. Trop. Dis. 4: e844.

 

Vondran FW, Timrott K, Tross J, Kollrich S, Gwinner W, Lehner F, Klempnauer J, Becker T, Schwinzer R.

Association of high anti-donor alloreactivity and low frequency of FoxP3 expressing cells prior to kidney transplantation with acute graft rejection.

Clin Transplant. 2011 Nov-Dec;25(6):905-14.

 

Ding X, Reimann S, Timrott K, Gutenbrunner C, Schwarze M, Fischer MJ.

Comparison of the ICF core set for cardiopulmonary conditions in the acute hospital setting among different types of transplant patients.

Int J Rehabil Res. 2010 Dec;33(4):325-31.

 

Schrem H, Reichert B, Frühauf N, Kleine M, Zachau L, Becker T, Lehner F, Bektas H, Klempnauer J.

[Extended donor criteria defined by the German Medical Association : Study on their usefulness as prognostic model for early outcome after liver transplantation.]

Chirurg 2012 Jul 20.

 

Vondran FW, Timrott K, Tross J, Kollrich S, Schwarz A, Lehner F, Klempnauer J, Becker T, Schwinzer R.

Impact of Basiliximab on regulatory T-cells early after kidney transplantation: down-regulation of CD25 by receptor modulation.

Transpl Int. 2010 May 1;23(5):514-23.

 

 

2008

 

N. Raschzok, M.H. Morgul, J. Pinkernelle, F.W.R. Vondran, N. Billecke, N. Kammer, G. Pless, M.K. Adonopoulou, C. Leist, L. Stelter, U. Teichgraber, R. Schwartlander, I.M. Sauer
Imaging of Primary Human Hepatocytes Using Micron-Sized Iron Oxide Particles and Clinical Magnetic Resonance Tomography.

J Cell Mol Med. 2008 Aug, 12 (4): 1384-94.

 

M.H. Morgul, N.Raschzok, R. Schwartlander, F.W.R. Vondran, R. Michel, L. Stelter, J. Pinkernelle, A. Jordan, U. Teichgraber, I.M. Sauer.

Tracking of primary human hepatocytes with clinical MRI – initial results with Tat-peptide modified superparamagnetic iron oxide particles.
Int J of Artificial Organs 2008 Mar, 31(3):252-7.

 

F.W.R. Vondran, E. Katenz, R. Schwartlander, M.H. Morgul, N. Raschzok, X. Gong, X. Cheng, D. Kehr, I.M. Sauer.

Isolation of primary human hepatocytes after partial hepatectomy – Criteria for identification of the most promising liver specimen.

Artif. Organs 2008 Mar, 32(3): 205-13.

 

Kleine M, Schrem H, Borlak J, Klempnauer J.

Clinical versatility of porcine hepatocytes in the light of interspecies differences in cytochrome P450 regulation and expression.

Xenotransplantation. 2008 Jul-Aug;15(4):208-17.

 

T. Lieke, S. Nylén, L. Eidsmo, W.R. McMaster, A.M. Mohammadi, A. Khamesipour, L. Berg, H. Akuffo.

Leishmania surface protein gp63 binds directly to human natural killer cells and inhibits proliferation.

Clin Exp. Immunol. 153: 221-230.

 

 

2007

 

F.W.R. Vondran*, E. Katenz*, R. Schwartlander, G. Pless, X. Gong, X. Cheng, P. Neuhaus, I.M. Sauer.
Cryopreservation of primary human hepatocytes – the benefit of trehalose as an additional cryoprotective agent.
Liver Transpl. 2007 Jan;13(1):38-45.

 

R. Schwartlander, J. Schmid, B. Brandenburg, E. Katenz, F.W.R. Vondran, G. Pless, X. Cheng, A. Pascher, P. Neuhaus, I.M. Sauer.
Continuously microscopically observed and process controlled cell culture within the SlideReactor – proof of a new concept for cell characterization.
Tissue Engineering 2007 Jan, 13(1):187-96.

 

Jäger MD, Liu JY, Timrott KF, Popp FC, Stoeltzing O, Lang SA, Piso P, Geissler EK, Schlitt HJ, Dahlke MH.
Sirolimus promotes tolerance for donor and recipient antigens after MHC class II disparate bone marrow transplantation in rats.

Exp Hematol. 2007 Jan., 35(1):164-70

 

 

2006

 

C. Furth, T. Denecke, J. Ruf, I. Steffen, T. Volker, D. Misch, F.W.R. Vondran, M. Plotkin, B. Stover, G. Henze, A.J. Lemke, H. Amthauer.

Correlative imaging strategies implementing CT, MRI and PET for staging of childhood Hodgkin´s disease.

J Pediatr Hema Oncol 2006

 

Schrem H, Kleine M, Borlak J, Klempnauer J.

Physiological incompatibilities of porcine hepatocytes for clinical liver support.

Liver Transpl. 2006 Dec;12(12):1832-40.

 

Koenecke C, Kleine M, Schrem H, Krug U, Nashan B, Neipp M, Ganser A, Hertenstein B, Klempnauer J.

Sinusoidal obstruction syndrome of the liver after hematopoietic stem cell transplantation: decision making for orthotopic liver transplantation.

Int J Hematol. 2006 Apr;83(3):271-4.

 

T. Lieke, C. Steeg, S. Graefe, B. Fleischer, T. Jacobs.

Interactions of natural killer cells with Trypanosoma cruzi-infected fibroblasts.

Clin. Exp. Immunol. 145: 357-364.

 

 

2005

 

I.M. Sauer, R. Schwartlander, J. Schmid, E. Efimova, F.W.R. Vondran, D. Kehr, G. Pless, A. Spinelli, B. Brandenburg, E. Hildt, P. Neuhaus.

The SlideReactor - a simple hollow fiber based bioreactor suitable for light microscopy.

Artificial Organs 2005

 

 

2004

 

T. Lieke, S. Gräfe, U. Klauenberg, B. Fleischer, T. Jacobs.

NK cells contribute to the control of Trypanosoma cruzi infection by killing free parasites by Perforin-independent mechanisms.

Inf. Immun. 72: 6817-6825.